Selected research
Industry Research
Lurasidone Industry Research Report 2026
Market perspective
The global Lurasidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lurasidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lurasidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lurasidone include Zhejiang Hisun Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Square Pharmaceuticals Ltd., RemedyRepack，Inc., Incepta Pharmaceuticals Ltd., Healthcare Pharmaceuticals Limited, Bushu Pharmaceutical, LTD. and Angelini Holding S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lurasidone market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lurasidone Market by Company
Zhejiang Hisun Pharmaceutical Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Square Pharmaceuticals Ltd.
RemedyRepack，Inc.
Incepta Pharmaceuticals Ltd.
Healthcare Pharmaceuticals Limited
Bushu Pharmaceutical, LTD.
Angelini Holding S.p.A.
Lurasidone Segment by Type
120mg/tablet
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
Lurasidone Segment by Application
Hospital
Psychological Clinic
Others
Lurasidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lurasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lurasidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lurasidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lurasidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 120mg/tablet
- 20mg/tablet
- 40mg/tablet
- 60mg/tablet
- 80mg/tablet
Applications
- Hospital
- Psychological Clinic
- Others
Companies covered
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Sumitomo Dainippon Pharma Co., Ltd.
- Square Pharmaceuticals Ltd.
- RemedyRepack，Inc.
- Incepta Pharmaceuticals Ltd.
- Healthcare Pharmaceuticals Limited
- Bushu Pharmaceutical, LTD.
- Angelini Holding S.p.A.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lurasidone Market Size (2021-2032)
- 2.2.2 Global Lurasidone Sales (2021-2032)
- 2.2.3 Global Lurasidone Market Average Price (2021-2032)
- 2.3 Lurasidone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 120mg/tablet
- 2.3.3 20mg/tablet
- 2.3.4 40mg/tablet
- 2.3.5 60mg/tablet
- 2.3.6 80mg/tablet
- 2.4 Lurasidone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Psychological Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lurasidone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lurasidone Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lurasidone Revenue of Manufacturers (2021-2026)
- 3.4 Global Lurasidone Average Price by Manufacturers (2021-2026)
- 3.5 Global Lurasidone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lurasidone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lurasidone, Product Type & Application
- 3.8 Global Manufacturers of Lurasidone, Established Date
- 3.9 Global Lurasidone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
- 4.1.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
- 4.1.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Sumitomo Dainippon Pharma Co., Ltd.
- 4.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
- 4.2.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
- 4.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
- 4.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
- 4.3 Square Pharmaceuticals Ltd.
- 4.3.1 Square Pharmaceuticals Ltd. Company Information
- 4.3.2 Square Pharmaceuticals Ltd. Business Overview
- 4.3.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
- 4.3.5 Square Pharmaceuticals Ltd. Recent Developments
- 4.4 RemedyRepack，Inc.
- 4.4.1 RemedyRepack，Inc. Company Information
- 4.4.2 RemedyRepack，Inc. Business Overview
- 4.4.3 RemedyRepack，Inc. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 RemedyRepack，Inc. Lurasidone Product Portfolio
- 4.4.5 RemedyRepack，Inc. Recent Developments
- 4.5 Incepta Pharmaceuticals Ltd.
- 4.5.1 Incepta Pharmaceuticals Ltd. Company Information
- 4.5.2 Incepta Pharmaceuticals Ltd. Business Overview
- 4.5.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
- 4.5.5 Incepta Pharmaceuticals Ltd. Recent Developments
- 4.6 Healthcare Pharmaceuticals Limited
- 4.6.1 Healthcare Pharmaceuticals Limited Company Information
- 4.6.2 Healthcare Pharmaceuticals Limited Business Overview
- 4.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
- 4.6.5 Healthcare Pharmaceuticals Limited Recent Developments
- 4.7 Bushu Pharmaceutical, LTD.
- 4.7.1 Bushu Pharmaceutical, LTD. Company Information
- 4.7.2 Bushu Pharmaceutical, LTD. Business Overview
- 4.7.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
- 4.7.5 Bushu Pharmaceutical, LTD. Recent Developments
- 4.8 Angelini Holding S.p.A.
- 4.8.1 Angelini Holding S.p.A. Company Information
- 4.8.2 Angelini Holding S.p.A. Business Overview
- 4.8.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
- 4.8.5 Angelini Holding S.p.A. Recent Developments
5 Global Lurasidone Market Scenario by Region
- 5.1 Global Lurasidone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lurasidone Sales by Region: 2021-2032
- 5.2.1 Global Lurasidone Sales by Region: 2021-2026
- 5.2.2 Global Lurasidone Sales by Region: 2027-2032
- 5.3 Global Lurasidone Revenue by Region: 2021-2032
- 5.3.1 Global Lurasidone Revenue by Region: 2021-2026
- 5.3.2 Global Lurasidone Revenue by Region: 2027-2032
- 5.4 North America Lurasidone Market Facts & Figures by Country
- 5.4.1 North America Lurasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lurasidone Sales by Country (2021-2032)
- 5.4.3 North America Lurasidone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lurasidone Market Facts & Figures by Country
- 5.5.1 Europe Lurasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lurasidone Sales by Country (2021-2032)
- 5.5.3 Europe Lurasidone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Lurasidone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lurasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lurasidone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lurasidone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lurasidone Market Facts & Figures by Country
- 5.7.1 South America Lurasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lurasidone Sales by Country (2021-2032)
- 5.7.3 South America Lurasidone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Lurasidone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lurasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lurasidone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lurasidone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lurasidone Sales by Type (2021-2032)
- 6.1.1 Global Lurasidone Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lurasidone Sales Market Share by Type (2021-2032)
- 6.2 Global Lurasidone Revenue by Type (2021-2032)
- 6.2.1 Global Lurasidone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lurasidone Revenue Market Share by Type (2021-2032)
- 6.3 Global Lurasidone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lurasidone Sales by Application (2021-2032)
- 7.1.1 Global Lurasidone Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lurasidone Sales Market Share by Application (2021-2032)
- 7.2 Global Lurasidone Revenue by Application (2021-2032)
- 7.2.1 Global Lurasidone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lurasidone Revenue Market Share by Application (2021-2032)
- 7.3 Global Lurasidone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lurasidone Value Chain Analysis
- 8.1.1 Lurasidone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lurasidone Production Mode & Process
- 8.2 Lurasidone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lurasidone Distributors
- 8.2.3 Lurasidone Customers
9 Global Lurasidone Analyzing Market Dynamics
- 9.1 Lurasidone Industry Trends
- 9.2 Lurasidone Industry Drivers
- 9.3 Lurasidone Industry Opportunities and Challenges
- 9.4 Lurasidone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst